FDA Approves Pirtobrutinib for Previously Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
The FDA approved pirtobrutinib for untreated chronic lymphocytic leukemia and small lymphocytic lymphoma without 17p deletion.
ALL ABOUT DAILYZ HEALTH NEWS
ALL ABOUT DAILYZ HEALTH NEWS
Source/Disclosures Published by: Disclosures: Marks and Weir report no relevant financial disclosures. ADD TOPIC TO EMAIL ALERTS Receive an email
Read MoreThe case for plant-based eating to reduce the burden of diabetes has never been stronger. There are all sorts of
Read MoreADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to
Read MoreDemocratic presidential candidate Robert F. Kennedy Jr., the latest scion of the Kennedy clan to seek the presidency, has a
Read MoreMISSOULA, Mont. — Yu Yu Htwe had never had dental problems, so she was surprised when a dentist told her
Read MoreNoam N. Levey Human Rights Watch, the nonprofit that for decades has called attention to the victims of war, famine,
Read MoreA UK parliamentary committee has found that former UK prime minister Boris Johnson intentionally misled parliament over illegal Covid-19 lockdown
Read MoreADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to
Read MoreRita K. Kuwahara, MD, MIH Access to preventive care is critical for our patients to maintain optimal health. As physicians,
Read MoreMedical syringes and Novavax logo displayed in the background are seen in this illustration photo taken in Krakow, Poland on
Read More